Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone mineral density in older HIV-1 infected subjects on TDF-based versus non-TDF antiretroviral regimens
NL-OMON39867Phase 4Active, not recruiting
- Sponsor
- Gilead Sciences
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences. Primary endpoints: Femoral neck T-score and Spine L1-4 T-score. Started Jul 2013; status: active, not recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON39867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39867.